GERM-LINE P53 MUTATION IS UNCOMMON IN PATIENTS WITH TRIPLE PRIMARY CANCERS

被引：24

作者：

SHISEKI, M

NISHIKAWA, R

YAMAMOTO, H

OCHIAI, A

SUGIMURA, H

SHITARA, N

SAMESHIMA, Y

MIZOGUCHI, H

SUGIMURA, T

YOKOTA, J

机构：

[1] NATL CANC CTR, RES INST, DIV BIOL, 1-1 TSUKIJI 5 CHOME, CHUO KU, TOKYO 104, JAPAN

[2] TOKYO WOMENS MED COLL, DEPT HEMATOL, SHINJUKU KU, TOKYO 162, JAPAN

[3] NATL CANC CTR, CHUO KU, TOKYO 104, JAPAN

[4] NATL CANC CTR, RES INST, DIV PATHOL, CHUO KU, TOKYO 104, JAPAN

[5] HAMAMATSU UNIV SCH MED, HAMAMATSU, SHIZUOKA 43131, JAPAN

[6] KOMAGOME METROPOLITAN HOSP, BUNKYO KU, TOKYO 113, JAPAN

来源：

CANCER LETTERS | 1993年 / 73卷 / 01期

关键词：

LI-FRAUMENI SYNDROME; GERM-LINE P53 MUTATION; MULTIPLE PRIMARY CANCERS; TUMOR SUPPRESSOR GENE;

D O I：

10.1016/0304-3835(93)90187-E

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We examined five patients with multiple primary cancers who had a history of three different types of primary cancers for germ-line p53 mutations. The germ-line p53 mutation was detected in a patient who conformed to the Li-Fraumeni syndrome, but not in the other four patients. The diagnosis of these four patients did not fall in the category of Li-Fraumeni syndrome. This result indicates that germ-line p53 mutations are uncommon even in patients with triple primary cancers.

引用

页码：51 / 57

页数：7

共 50 条

[41] P53 GENE MUTATION IN URINARY-TRACT CANCERS
OKAJIMA, E
FUJIMOTO, K
KAKIZOE, T
TERADA, M
AKTUELLE UROLOGIE, 1993, 24 : 96 - 98
[42] A germ-line p53 mutation accelerates pulmonary tumorigenesis:: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin
Zhang, ZQ
Liu, Q
Lantry, LE
Wang, Y
Kelloff, GJ
Anderson, MW
Wiseman, RW
Lubet, RA
You, M
CANCER RESEARCH, 2000, 60 (04) : 901 - 907
[43] TESTING FOR GERM LINE P53 MUTATIONS IN CANCER FAMILIES
LI, FP
CORREA, P
FRAUMENI, JF
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1991, 1 (01) : 91 - 94
[44] DETECTION OF GERM LINE P53 MUTATIONS IN HEREDITARY CANCER
MALKIN, D
FRIEND, S
CLINICAL CHEMISTRY, 1992, 38 (03) : 452 - 453
[45] Analysis of the p53 gene mutations in patients with multiple primary cancers of the oesophagus
Mayama, T
Mori, T
Abe, K
Sasano, H
Nishihira, T
Satomi, S
Horii, A
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (04): : 298 - 303
[46] GERM-LINE MUTATIONS OF THE APC GENE IN 53 FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS
MIYOSHI, Y
ANDO, H
NAGASE, H
NISHISHO, I
HORII, A
MIKI, Y
MORI, T
UTSUNOMIYA, J
BABA, S
PETERSEN, G
HAMILTON, SR
KINZLER, KW
VOGELSTEIN, B
NAKAMURA, Y
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4452 - 4456
[47] Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population
Yamada, Hidetaka
Shinmura, Kazuya
Okudela, Koji
Goto, Masanori
Suzuki, Masaya
Kuriki, Ken
Tsuneyoshi, Toshihiro
Sugimura, Haruhiko
CARCINOGENESIS, 2007, 28 (09) : 2013 - 2018
[48] Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers
Umeda, Junko
Itoi, Takao
Sofuni, Atsushi
Itokawa, Fumihide
Kurihara, Toshio
Tsuchiya, Takayoshi
Ishii, Kentaro
Tsuji, Shujiro
Ikeuchi, Nobuhito
Tanaka, Reina
Tonozuka, Ryosuke
Honjo, Mitsuyoshi
Mukai, Shuntaro
Nagao, Toshitaka
Oshiro, Hisashi
Moriyasu, Fuminori
JOURNAL OF ONCOLOGY, 2013, 2013
[49] The influence of oxidative damaged base on germ-line mutation
Ohno, Mizuki
Sakumi, Kunihiko
Furuichi, Masato
Tsuzuki, Teruhisa
Nakabeppu, Yusaku
GENES & GENETIC SYSTEMS, 2009, 84 (06) : 461 - 461
[50] The detection of p53 gene mutation using a microdissection technique in primary intracranial germ cell tumors
Kim, SK
Cho, BK
Paek, SH
Hong, SJ
Kim, HS
Hong, SY
Choe, G
Chi, JG
Nam, DH
Wang, KC
INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (01) : 111 - 116

← 1 2 3 4 5 →